Oral contraception: Five important issues

Simple item page
dc.contributor.authorSlabbert D.R.
dc.contributor.authorKruger T.F.
dc.contributor.authorSteyn P.S.
dc.date.accessioned2011-05-15T16:17:59Z
dc.date.available2011-05-15T16:17:59Z
dc.date.issued2005
dc.description.abstractThe dosage of the hormones used in the combined oral contraceptive pill have, over the past 40 years, continually decreased in order to provide formulations with minimum side effects while still retaining efficacy. Women are concerned that long-term use of combined oral contraceptives (COCs) increases health risks (including an increased risk of cancer or cardiovascular disease). In this article we would like to highlight some of the above issues and some of the commonly asked questions. This would enable us to provide the necessary advice and guidance to our patients. Oral contraception is an area in the health sector where new products are constantly developed and this means that, to give patients the best available advice, general practitioners, pharmacists and gynaecologists need to stay abreast with the latest literature and developments.
dc.description.versionReview
dc.identifier.citationSouth African Family Practice
dc.identifier.citation47
dc.identifier.citation1
dc.identifier.issn1726426X
dc.identifier.urihttp://hdl.handle.net/10019.1/14460
dc.subjectdrospirenone
dc.subjectdrospirenone plus ethinylestradiol
dc.subjectestrogen
dc.subjectethinylestradiol
dc.subjectgestagen
dc.subjectlevonorgestrel
dc.subjectnorethisterone
dc.subjectoral contraceptive agent
dc.subjectbody mass
dc.subjectbreast cancer
dc.subjectcancer
dc.subjectcancer risk
dc.subjectcardiovascular disease
dc.subjectcolorectal cancer
dc.subjectdrug contraindication
dc.subjectdrug dose reduction
dc.subjectdrug effect
dc.subjectdrug efficacy
dc.subjectdrug formulation
dc.subjectdrug megadose
dc.subjectdrug safety
dc.subjectendometrium cancer
dc.subjectfemale fertility
dc.subjectfluid retention
dc.subjecthuman
dc.subjectliver cancer
dc.subjectlong term care
dc.subjectlow drug dose
dc.subjectoral contraception
dc.subjectovary cancer
dc.subjectpregnancy rate
dc.subjectreview
dc.subjectrisk assessment
dc.subjectrisk reduction
dc.subjectside effect
dc.subjectuterine cervix cancer
dc.subjectuterine cervix carcinoma in situ
dc.subjectvaricosis
dc.subjectvenous thromboembolism
dc.subjectweight gain
dc.titleOral contraception: Five important issues
dc.typeReview
Files
Collections
Stellenbosch University - Scopus Tygerberg Hospital Publications